(Q35754000)

10 August 2017

Impact of a scientific presentation on community treatment patterns for primary breast cancer (English)

1 reference

10 August 2017

Sharon H Giordano

1

0 references

Gabriel N Hortobagyi

4

object named as

Gabriel N Hortobagyi

1 reference

10 August 2017

Zhigang Duan

2

1 reference

10 August 2017

Yong-Fang Kuo

3

1 reference

10 August 2017

Jean Freeman

5

1 reference

10 August 2017

James S Goodwin

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Journal of the National Cancer Institute

10 August 2017

1 reference

10 August 2017

98

1 reference

10 August 2017

6

1 reference

10 August 2017

382-388

1 reference

10 August 2017

Cancer statistics, 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Revision of the American Joint Committee on Cancer staging system for breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Use of the statins in patients after acute myocardial infarction: does evidence change practice?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Patterns of care related to age of breast cancer patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Adjuvant docetaxel for node-positive breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Potential for cancer related health services research using a linked Medicare-tumor registry database.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Determinants of cancer therapy in elderly patients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1853252

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

25 September 2018

1 reference

12 December 2020

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

12 December 2020

Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients

1 reference

12 December 2020

Choice of cancer therapy varies with age of patient

1 reference

12 December 2020

Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJJ090

1 reference

10 August 2017

1 reference

10 August 2017

1 reference